Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01366131 | Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE) | completed | Phase 2 | 104 | Genentech, Inc.INDUSTRY | 7 | Nov 2, 2016 | clinicaltrials |
| NCT00753714 | Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine(ZELIG) | completed | Phase 2 | 124 | Genzyme, a Sanofi CompanyINDUSTRY |
| 1 |
| Oct 17, 2016 |
| clinicaltrials |
| NCT00777179 | Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy | completed | Phase 2 | 117 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Oct 10, 2016 | clinicaltrials |
| NCT00741195 | Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00741221 | Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00753909 | Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00755170 | Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 48 | Hellenic Oncology Research GroupOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00216203 | Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Nasser Hanna, M.D.OTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT01496742 | A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 259 | Genentech, Inc.INDUSTRY | 13 | Sep 23, 2016 | clinicaltrials |
| NCT00824408 | Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC | completed | Phase 2 | 143 | Boehringer IngelheimINDUSTRY | 2 | Sep 20, 2016 | clinicaltrials |
| NCT00525148 | LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations | completed | Phase 2 | 129 | Boehringer IngelheimINDUSTRY | 2 | Sep 16, 2016 | clinicaltrials |
| NCT00323869 | Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | Stanford UniversityOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01519804 | A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 108 | Genentech, Inc.INDUSTRY | 9 | Sep 2, 2016 | clinicaltrials |
| NCT01221675 | TF2- Small Cell Lung Cancer Radio Immunotherapy | completed | Phase 1 / Phase 2 | 18 | Centre René GauducheauOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00047840 | This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. | completed | Phase 2 | 129 | Genzyme, a Sanofi CompanyINDUSTRY | 3 | Aug 25, 2016 | clinicaltrials |
| NCT00071188 | ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | Genzyme, a Sanofi CompanyINDUSTRY | 9 | Aug 25, 2016 | clinicaltrials |
| NCT00252746 | ZD6474 Phase IIa Dose Finding Multicentre Study | completed | Phase 2 | 53 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Aug 25, 2016 | clinicaltrials |
| NCT00059722 | This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. | completed | Phase 2 | 160 | Genzyme, a Sanofi CompanyINDUSTRY | 6 | Aug 24, 2016 | clinicaltrials |
| NCT00994123 | A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 162 | Merrimack PharmaceuticalsINDUSTRY | 6 | Aug 22, 2016 | clinicaltrials |
| NCT01045421 | Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies | completed | Phase 1 / Phase 2 | 273 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 15, 2016 | clinicaltrials |
| NCT02774278 | A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC)(MERIT) | completed | Phase 2 | 264 | Hoffmann-La RocheINDUSTRY | 14 | Aug 8, 2016 | clinicaltrials |
| NCT00826449 | Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT01788566 | A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer | completed | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 7 | Jun 27, 2016 | clinicaltrials |
| NCT01194453 | Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer(AP/GP) | completed | Phase 2 | 288 | Sun Yat-sen UniversityOTHER | 1 | Jun 16, 2016 | clinicaltrials |
| NCT00508625 | A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab | completed | Phase 2 | 213 | AmgenINDUSTRY | 0 | Jun 14, 2016 | clinicaltrials |
| NCT01666977 | Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | AmgenINDUSTRY | 6 | Jun 3, 2016 | clinicaltrials |
| NCT00259064 | Iressa v BSC (Best Supportive Care) in First Line NSCLC(INSTEP) | completed | Phase 2 / Phase 3 | 216 | AstraZenecaINDUSTRY | 5 | Jun 2, 2016 | clinicaltrials |
| NCT00642473 | A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash(MATER) | completed | Phase 2 | 34 | Hoffmann-La RocheINDUSTRY | 1 | May 23, 2016 | clinicaltrials |
| NCT01047059 | Molecular Imaging With Erlotinib and Bevacizumab(MIMEB) | completed | Phase 2 | 40 | University of CologneOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT00651508 | Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1 | Bristol-Myers SquibbINDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT00518011 | A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. | completed | Phase 2 | 17 | Hoffmann-La RocheINDUSTRY | 1 | May 16, 2016 | clinicaltrials |
| NCT01291017 | Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. | completed | Phase 2 | 19 | University of FloridaOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT01042288 | Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC | completed | Phase 2 | 70 | SCRI Development Innovations, LLCOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01792479 | A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 64 | BIND TherapeuticsINDUSTRY | 2 | Apr 15, 2016 | clinicaltrials |
| NCT00609804 | Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib | completed | Phase 2 | 53 | SCRI Development Innovations, LLCOTHER | 1 | Apr 8, 2016 | clinicaltrials |
| NCT02720614 | Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer | completed | Phase 2 | 12 | LIN QIANGOTHER | 0 | Mar 28, 2016 | clinicaltrials |
| NCT00094835 | Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 51 | AmgenINDUSTRY | 0 | Mar 24, 2016 | clinicaltrials |
| NCT00888823 | Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 13 | AHS Cancer Control AlbertaOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT01297491 | Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer(BASALT-1) | completed | Phase 2 | 63 | Novartis PharmaceuticalsINDUSTRY | 18 | Mar 11, 2016 | clinicaltrials |
| NCT00198432 | Chemoradiotherapy of NSCLC Stage IIIB | completed | Phase 2 | 130 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01124864 | A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. | completed | Phase 2 | 153 | Novartis PharmaceuticalsINDUSTRY | 10 | Mar 2, 2016 | clinicaltrials |
| NCT01769066 | Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC | completed | Phase 2 / Phase 3 | 117 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01810367 | ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC | completed | Phase 2 | 84 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00940069 | TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer(TPEIAL) | completed | Phase 2 | 60 | Hunan Province Tumor HospitalOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT02256852 | Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer | completed | Phase 2 | 6 | Qu Biologics Inc.INDUSTRY | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00035516 | A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy | completed | Phase 2 | — | R-PharmINDUSTRY | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01372384 | A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations | completed | Phase 2 | 6 | Hoffmann-La RocheINDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01836679 | Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 124 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Feb 1, 2016 | clinicaltrials |
| NCT01027598 | Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer | completed | Phase 2 | 202 | SCRI Development Innovations, LLCOTHER | 1 | Jan 29, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Nov 2, 2016source: clinicaltrials